Korean Drug Co., Ltd. (KOSDAQ: 014570)

Korean Drug Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	54,560	78,348	85,441	97,444	112,394	78,457
Market Cap Growth	-16.16%	-8.30%	-12.32%	-13.30%	43.25%	-0.42%
Enterprise Value	36,620	41,605	53,950	71,749	92,548	67,689
Last Close Price	5000.00	7180.00	7664.81	8545.90	9669.11	6649.86
PE Ratio	-	-15.75	7.00	10.32	14.28	18.63
PS Ratio	0.69	0.96	1.07	1.31	1.68	1.41
PB Ratio	0.69	1.02	1.01	1.27	1.59	1.21
P/FCF Ratio	-4.38	-10.03	-474.28	12.72	9.70	24.86
P/OCF Ratio	-5.66	-39.20	14.45	11.07	9.12	12.64
EV/Sales Ratio	0.47	0.51	0.67	0.96	1.39	1.22
EV/EBITDA Ratio	9.96	4.91	3.43	5.63	7.47	14.71
EV/EBIT Ratio	21.90	6.19	3.77	6.37	8.38	19.81
EV/FCF Ratio	-2.65	-5.33	-299.47	9.37	7.98	21.45
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.01	0.01	0.00	0.00	0.02
Debt / FCF Ratio	-0.01	-0.01	-0.45	0.01	0.00	0.03
Asset Turnover	0.79	0.88	0.87	0.87	0.84	0.75
Inventory Turnover	2.25	2.74	3.41	3.67	3.37	3.23
Quick Ratio	4.00	4.52	7.81	5.51	5.13	4.62
Current Ratio	5.96	6.41	9.80	6.82	6.44	6.15
Return on Equity (ROE)	-1.56%	-6.08%	14.63%	12.26%	10.83%	6.09%
Return on Assets (ROA)	1.06%	4.56%	9.78%	8.19%	8.67%	2.87%
Return on Capital (ROIC)	1.31%	5.19%	11.09%	9.54%	10.14%	3.34%
Earnings Yield	-2.31%	-6.28%	13.82%	9.28%	6.55%	4.96%
FCF Yield	-25.35%	-9.97%	-0.21%	7.86%	10.31%	4.02%
Payout Ratio	0.00%	-	15.52%	18.07%	14.80%	27.99%
Buyback Yield / Dilution	0.21%	0.01%	1.25%	-0.46%	0.37%	0.07%
Total Shareholder Return	3.21%	0.01%	1.25%	-0.46%	0.37%	0.07%

Source: S&P Capital IQ. Standard template. Financial Sources.